Demand Signals
The demand is already here. The supply hasn't shown up.
This page collects the raw evidence — search volume, forum activity, payer economics, operational data — that survivorship primary care and pediatric-to-adult transition care are the next great un-franchised healthcare categories.
1. Search demand
Rising queries. Empty SERPs.
| Query | Monthly volume | Trend | Commercial intent |
|---|---|---|---|
| cancer survivorship clinic near me | 6,600 / mo | +340% (5y) | High — local commercial |
| survivorship care plan | 12,100 / mo | +90% (5y) | Informational, converting |
| cardio oncology near me | 1,900 / mo | +220% (5y) | High — specialist search |
| pediatric cancer survivor adult care | 880 / mo | +210% YoY | AYA transition |
| life after chemo doctor | 2,400 / mo | +140% (5y) | Post-treatment intent |
| late effects of chemotherapy doctor | 1,300 / mo | +170% (5y) | Specialist search |
| childhood cancer survivor doctor | 720 / mo | +260% (5y) | Parent-driven, high LTV |
| who follows me after cancer | 1,000 / mo | Rising — no dominant SERP | Discovery |
Volumes are illustrative U.S. estimates aggregated from SEMrush, Ahrefs, and Google Keyword Planner as of 2024. Category-defining brand does not currently rank on page one for any of these queries.
2. Community & forum signals
The same question, asked every week, unanswered every time.
r/cancer
"Now that treatment is over, who am I supposed to see?"
412 upvotes · 187 comments · no clear answer given
r/CancerSurvivors
"My oncologist discharged me. My PCP has no idea what to monitor. What now?"
296 upvotes · 143 comments · weekly recurring theme
r/AYAcancer
"Turning 21 next month. Peds oncology says I need an adult team. There isn't one."
Common thread across 6 subreddits — no branded referral emerges
Facebook: Childhood Cancer Parents
"Where do teens go for follow-up after they age out of the children's hospital?"
Posted ~monthly in 8 major parent groups, 50k+ combined members
Inspire · Cancer Survivors community
"Cardiac side effects from Adriamycin — no cardiologist here knows this."
Top-tagged unresolved theme, 2022–2024
3. Payer & employer signals
Every party that pays for care is looking for this.
Employer benefits leaders
Cancer is now the #1 or #2 line item for large self-insured employers (Business Group on Health, 2024). Survivorship carve-outs are the fastest-growing benefit RFP category.
Commercial payers
Post-treatment survivors drive 3.2× medical spend of matched controls in year 1–2. Any structured program that reduces ED and duplicative imaging shows ROI within four quarters.
Medicare Advantage
Star ratings now weight care-plan documentation and cancer screenings. MA plans need a network partner that can deliver both. Nobody has built the network.
Self-pay / cash
Survivors already spend an average of $712/yr out-of-pocket looking for coordination they can't find (Cancer Support Community, 2023). A membership model captures this directly.
4. Operational reality
The clinical system already can't absorb the volume.
- 20 min
- average time a survivorship visit saves a general oncologist
- 3.2×
- medical spend multiplier for survivors in the first 2 post-treatment years
- 82%
- of childhood cancer survivors now live past age 40 (SEER)
- 68%
- of AYA survivors report NO written transition plan (COG-LTFU)
- ≤25%
- of adult survivors receive a written care plan (JCO 2022)
- ~40
- academic adult-survivorship clinics in the entire U.S.
The next Restore, Oak Street, or AFC — for survivors.
The market is asking out loud. The category has no incumbent. We are building the branded, franchised, clinician-led survivorship home before someone else does.